Form 4 for AGIO AGIOS PHARMACEUTICALS, INC.
Accepted 2023-06-23 00:00:00 ET · period of report 2023-06-21 · accession 0001439222-23-000093 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-23 | 2023-06-21 | AGIO | Scadden David | Dir | M - OptEx | $0.00 | +4,975 | 12.1K | +70% | $0 |
| D | 2023-06-23 | 2023-06-21 | AGIO | Scadden David | Dir | M - OptEx | $0.00 | -4,975 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2023-06-21 | M | A | 4,975 | $0.00 | 12,095 | D | — | — | |
| 2 | Derivative | Restricted stock unit | 2023-06-21 | M | D | 4,975 | $0.00 | 0 | D | — · — to — | 4,975 Common stock | (F1) Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. (F2) The restricted stock units were granted on June 21, 2022. The shares underlying the stock units will vest in full on June 21, 2023. Vested shares will be delivered to the reporting person within three business days after such shares become vested. |